Skip to main content

Clinical Trials Using Methylprednisolone

Review the clinical trials studying methylprednisolone on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 1-15 of 15

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants with Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
Status: Active
Location: 98 locations
A Study to Evaluate the Safety and Efficacy of Axatilimab in Combination With Ruxolitinib in Participants With Newly Diagnosed Chronic Graft-Versus-Host Disease
Status: Active
Location: 18 locations
A Study of CYP-001 in Combination With Corticosteroids in Adults With High-risk aGvHD
Status: Active
Location: 5 locations
The Study of 177Lu-TLX591 Plus SOC Versus SOC Alone in Patients With mCRPC (ProstACT Global)
Status: Active
Location: 4 locations
Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients with Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Infliximab or Corticosteroids for the Treatment of Immune Checkpoint Inhibitor Related Colitis
Status: Active
Location: 2 locations
Vedolizumab in Combination with Short Course of Steroids for the Treatment of Immune-Related Colitis, EVITA Trial
Status: Active
Location: Brigham and Women's Hospital, Boston, Massachusetts
Venetoclax, Tagraxofusp, and Chemotherapy for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Alpha/Beta T Cell Depleted Stem Cell Transplant in Treating Patients with Fanconi Anemia or Telomere Biology Disorder
Status: Active
Location: University of Minnesota/Masonic Cancer Center, Minneapolis, Minnesota
Ruxolitinib in Combination with Recombinant Human Chorionic Gonadotropin and Corticosteroids for the Treatment of Lower Gastrointestinal Acute Graft Versus Host Disease in Patients Who Have Undergone Hematopoietic Cell Transplant
Status: Active
Location: University of Minnesota/Masonic Cancer Center, Minneapolis, Minnesota
Hyper-CVAD in Combination with Venetoclax for the Treatment of Pediatric, Adolescent and Young Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
A Study of Changes to Prostate Procedures
Status: Active
Location: 2 locations
Non-invasive Ventilation in Reducing the Need for Intubation in Patients with Cancer and Respiratory Failure
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
High Dose Steroid Therapy (Prednisone or Methylprednisolone) for the Improvement of Symptoms of Late Radiation-Associated Lower Cranial Neuropathy in Oropharyngeal Cancer Survivors
Status: Temporarily Closed to Accrual
Location: M D Anderson Cancer Center, Houston, Texas
Premedication Regimens (Methylprednisolone/Dexamethasone) for the Prevention of Allergic Reaction to Motixafortide in Patients with Multiple Myeloma Undergoing Stem Cell Mobilization, PARADE Trial
Status: Active
Location: Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia